~Dr. Jerzy Zawistowski To Speak On A Panel About "New Products & Technologies"~
Vancouver, Canada Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) today announced that it will be exhibiting at the Institute of Food Technologists (IFT) Annual Meeting and Food Expo at the Orlando Convention Center (booth #3176) in Orlando, Florida from June 24-28, to showcase a number of Reducol(tm)-based products.
"Reducol(tm) is a natural, clinically proven ingredient to help you lower your cholesterol through the food you eat," noted Laura Wessman, Senior Vice President Operations at Forbes Medi-Tech. "Reducol(tm) continues to gain attention, especially in Europe. Shows like IFT will help us to better reach consumers and manufacturers in North America."
A range of products has been introduced containing Reducol(tm). Albert Heijn, from The Netherlands, has launched a range of cholesterol-lowering dairy products; Wal-Mart /ASDA in the UK has launched Heartfelt Plus Natural Cheddar Cheese; U.K. based Tesco offers a milk drink, yogurt drink, yogurt and margarine spread; and Finland's largest grocery chain Kesko has launched a range of yogurts called "Pirrka." Typically manufacturers in Europe have added Reducol(tm) to dairy products, however, the ingredient can be added to a wide variety of foods without altering the taste.
In North America, Reducol(tm) is currently available in a dietary supplement from NatureMade(tm) called CholestOff(r) and in a line of heart-healthy, sugar-free chocolates, called CardioPower Truffles, from Designs for Health.
Additionally, Forbes Medi-Tech's Dr. Jerzy Zawistowski, Vice President of Functional Foods and Nutraceuticals, is scheduled to speak on Sunday, June 25th as part of a panel on "New Products & Technologies: Innovations in Nutritional Ingredients and Analytical Methods".
For more information about the Institute of Food Technologists Annual Meeting and Food Expo visit: www.IFT.org.
Reducol(tm) is a unique ingredient containing plant sterols and stanols, commonly known as phytosterols, or "Sterols". The combination of a prudent diet and consumption of products containing the recommended amount of Reducol(tm) may help consumers lower their cholesterol by up to 24%. Additional information on Reducol(tm) can be found at www.reducol.com
About Forbes Medi-Tech Inc.
Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of cardiovascular disease (CVD). Our vision is to develop and market products along a treatment continuum that CVD savvy consumers,
healthcare professionals and specialized CVD research and healthcare nstitutions; will identify, recommend and seek. Our business strategy is to develop and commercialize proprietary compounds to address the unmet needsof patients within the cardiovascular disease market.
# # #
NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept
responsibility for the adequacy or accuracy of the content of this News
Release. The Food Expo and presentation referred to in this press release
are subject to change or cancellation without notice. This News Release
contains other forward-looking statements regarding the Company and its
business, which statements can be identified by the use of forward-looking
terminology such as "vision", "to develop",
"will", and "strategy". The Company's actual results could differ
materially from those anticipated in these forward-looking statements as a
result of numerous factors, including uncertainty whether Reducol will be
added to any additional foods or dietary supplements for commercial sale;
uncertainty regarding market acceptance and demand for products containing
Reducol; the need for new customers; product development risks; research
and development risks; uncertainty whether the Company will realize is
strategies and vision; intellectual property risks; manufacturing risks and
the need to manufacture to regulatory standards; product liability and
insurance risks; the effect of competition; and the Company's need for
future funding; any of which could cause actual results to vary materially
from current results or the Company's anticipated future results. See the
Company's reports filed with the Canadian and U.S. securities regulatory
authorities from time to time for cautionary statements identifying
important factors with respect to such forward-looking statements, including
certain risks and uncertainties, that could cause actual results to differ
materially from results referred to in forward-looking statements. The
Company assumes no obligation to update the information contained in this